WuXi AppTec Completes Second RMB1.0 Billion A-Share Repurchase Program in 2025, All Repurchased Shares to Be Cancelled
Rhea-AI Summary
WuXi AppTec (WUXAY) has completed its second RMB1.0 billion A-share repurchase program in 2025, with all repurchased shares scheduled for cancellation on August 28, 2025. The company repurchased 11,860,809 A-shares, representing 0.40% of total share capital, between June 26 and August 26, 2025.
This year, WuXi AppTec has executed RMB2.0 billion in total A-share repurchases. Combined with cash dividends, the company's shareholder returns in 2025 amount to RMB5.84 billion, exceeding 60% of the company's 2024 net profit attributable to owners.
Positive
- Total shareholder returns of RMB5.84 billion in 2025 through buybacks and dividends
- Significant return to shareholders exceeding 60% of 2024 net profit
- Completion of RMB2.0 billion in share repurchases year-to-date
Negative
- Share capital dilution of 0.40% prior to cancellation
News Market Reaction 1 Alert
On the day this news was published, WUXAY declined 0.31%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
On April 29, 2025, the Company's Annual General Meeting approved the
From June 26, 2025 to August 26, 2025, WuXi AppTec repurchased a total of 11,860,809 A-shares, representing
So far this year, WuXi AppTec has cumulatively completed
For more information, please refer to the Company's relevant announcement: Announcement on the completion of the repurchase of A shares of the Company for the first time in 2025 and cancellation of A shares of the Company.
About WuXi AppTec
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across
View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-completes-second-rmb1-0-billion-a-share-repurchase-program-in-2025--all-repurchased-shares-to-be-cancelled-302540052.html
SOURCE WuXi AppTec